| NDC Code | 0169-2911-97 |
| Package Description | 1 SYRINGE, PLASTIC in 1 CARTON (0169-2911-97) > 3 mL in 1 SYRINGE, PLASTIC (0169-2911-90) |
| Product NDC | 0169-2911 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Proprietary Name | Xultophy 100/3.6 |
| Non-Proprietary Name | (insulin Degludec And Liraglutide) |
| Dosage Form | INJECTION, SOLUTION |
| Usage | SUBCUTANEOUS |
| Start Marketing Date | 20161121 |
| Marketing Category Name | BLA |
| Application Number | BLA208583 |
| Manufacturer | Novo Nordisk |
| Substance Name | INSULIN DEGLUDEC; LIRAGLUTIDE |
| Strength | 100; 3.6 |
| Strength Unit | [iU]/mL; mg/mL |
| Pharmacy Classes | GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Insulin Analog [EPC], Insulin [CS] |